ARCHIVES

NCI apologize For Mismanagement Of NSABP, Says Fisher Resisted Criticism

This article is from The Cancer Letter archive.

Vol. 20 No. 16 | April 22, 1994

Download PDF Visit The Full Archive

Related Articles

ASCO to Present 2013 Special Awards at Annual Meeting

May 31, 2013

More money would speed progress, NCI says, but backs off previous commitment to meet 2015 goal by 2010.

July 29, 2005

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

September 24, 1999

New CCOP RFA Available; Briefing At ASCO Jammed

June 2, 1989

FDA Designates Zometa For Priority Review.

November 30, 2001

NCAB Committee Ok’s Recompetition of OD Support Contract

May 22, 1992